News
License Renewals Are Not Just Administrative: The Cost of Getting Them Wrong
For pharmaceutical manufacturers, wholesale distributors, 3PLs, repackagers, reverse distributors, and medical device companies, state license renewals are often viewed as routine paperwork. A deadline to track. A form to submit. A fee to pay. But in reality, state...
Drug Price Transparency Reporting: Preparing for Another Year of State-Level Scrutiny
Drug price transparency reporting remains one of the most challenging compliance obligations for pharmaceutical companies. While these requirements have been in place for several years, state legislatures and regulatory agencies continue to refine their expectations,...
DSCSA Compliance in Practice: What Trading Partner Verification Really Requires
The Drug Supply Chain Security Act (DSCSA) has been a focal point for the pharmaceutical industry for years. While much of the early effort centered on systems, data exchange, and stabilization, compliance expectations have clearly shifted. Regulators are no longer...
State Licensing in a Fragmented Supply Chain: Where Compliance Risks Hide
The pharmaceutical and medical device supply chain looks very different today than it did even a decade ago. What was once a more linear path from manufacturer to distributor has evolved into a highly interconnected network of partners, facilities, and outsourced...
Compliance in 2026: What Pharmaceutical and Medical Device Companies Should Be Preparing for Now
As the pharmaceutical and medical device industries move into 2026, compliance teams are facing a familiar reality with a new level of intensity. Regulatory expectations continue to expand, supply chains are more complex than ever, and state-level compliance...
Year-End Compliance Planning: How to Set Your Organization Up for a Smoother Licensing Year Ahead
As the year comes to a close, many pharmaceutical and medical device companies are focused on budgets, forecasts, and strategic planning. Too often state licensing and regulatory compliance is only addressed reactively once renewal notices arrive or issues surface....
How Law Firms Can Streamline CHOW Transactions and Strengthen Regulatory Support for Pharma Clients
Legal teams that advise pharmaceutical and medical device companies are taking on more responsibility each year as regulatory expectations grow across federal, state, and territorial agencies. Whether your firm handles mergers and acquisitions, stock sales, corporate...
Navigating the Maze: A Proactive Strategy for Wholesaler State Licensing and Regulatory Compliance
Managing licenses for a pharmaceutical or medical device wholesaler is never simple. Every state has its own rules, timelines, interpretations, and expectations. Even experienced compliance teams can miss requirements that lead to delays, fines, or disruptions in...
How Misaligned Licensing Between Manufacturers and 3PLs Create Serious Liability
The pharmaceutical supply chain has become more complex than ever. Manufacturers, virtual manufacturers, CMOs, and CDMOs rely heavily on third party logistics providers to manage distribution, storage, and transportation of finished goods. This networked model...